Community Events | NYU Langone Health
NYU Langone’s Pearl I. Barlow Center for Memory Evaluation and Treatment hosts regular educational events throughout the year.
Community Events at NYU Langone Hospital—Long Island | NYU Langone Health
NYU Langone Hospital—Long Island provides educational lectures, parent education classes, and support groups for the Long Island community.
Community Health Needs & Assets Assessment & Community Service Plan | NYU Langone Health
NYU Langone’s Community Health Needs and Assets Assessment and its Community Service Plan support behavior change and disease prevention.
Community Medicine Program—Family Health Centers at NYU Langone | NYU Langone Health
The Community Medicine Program—Family Health Centers at NYU Langone provides healthcare through homeless shelters in New York City.
Community Medicine Program—Family Health Centers at NYU Langone Doctors | NYU Langone Health
Find a doctor at Community Medicine Program—Family Health Centers at NYU Langone.
Community Outreach & Engagement at the Trauma Center at NYU Langone Hospital—Suffolk | NYU Langone Health
The Trauma Center at NYU Langone Hospital—Suffolk offers community outreach programs to educate people about the risk of injury.
Community Outreach & Engagement at Trauma Center at NYU Langone Hospital—Long Island | NYU Langone Health
The community outreach program at the Trauma Center at NYU Langone Hospital—Long Island aims to educate people about the risk of injury.
Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis
The purpose of this research study is to assess the performance of a new prostate biopsy instrument called SUREcore Plus and participants tolerance of its use. The study also aims to assess the performance of a new device called CoreCARE to retrieve tissue from the biopsy needle.
Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis
CAPTIVA is a two-stage Phase III trial randomizing subjects with stroke attributed to 70-99% intracranial atherosclerotic stenosis (sICAS) to 12 months treatment of:1) ticagrelor (180 mg loading dose, then 90mg twice daily) + aspirin 81 mg / day, or2) low dose rivaroxaban (2.5mg twice daily) + aspirin 81 mg / day, or3) clopidogrel (600mg loading dose, then 75 mg daily) + aspirin 81 mg/day. The primary goal of the trial is to determine if the experimental arm(s) (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of the primary endpoint (ischemic stroke, intracerebral hemorrhage (ICH), or vascular death).
Compartment Syndrome | NYU Langone Health
NYU Langone specialists manage acute and chronic compartment syndrome, potentially serious muscle conditions.